Qv Investors Inc. Haemonetics Corp Transaction History
Qv Investors Inc.
- $1.02 Billion
- Q2 2025
A detailed history of Qv Investors Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Qv Investors Inc. holds 14,440 shares of HAE stock, worth $725,465. This represents 0.11% of its overall portfolio holdings.
Number of Shares
14,440
Previous 11,240
28.47%
Holding current value
$725,465
Previous $714,000
50.84%
% of portfolio
0.11%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
336Shares Held
53.5MCall Options Held
540KPut Options Held
306K-
Black Rock Inc. New York, NY5.96MShares$299 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$249 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$215 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$108 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$94.7 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.58B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...